Recent public stories from this publisher.
1640 public articles
Paul Roetzer and Mike Kaput examine reported PHP vulnerabilities, financial-sector attacks, and AI-assisted security checks. Their strongest practical argument concerns the gap between discovering a flaw and protecting...
Paul Roetzer与Mike Kaput围绕PHP漏洞、针对金融机构的攻击及AI辅助排查，讨论漏洞发现提速为何未必立即带来安全。攻击尝试不等于实际失陷，补丁发布也不等于完成部署。应对风险，仍须落实到资产盘点、修补责任和代理权限。
ARK's Brainstorm discussion connects Anthropic's enterprise economics, Meta's consumer-agent ambitions, and the struggle to finance and deliver compute. Its strongest insight is that revenue timing shapes infrastructure...
这期《The Brainstorm》将企业AI变现、消费者智能体与新云供应商的竞争，归结为同一个资源分配问题：已经能够收费的需求，如何与仍在探索商业模式的产品争夺算力。Brett、Nick等讨论者给出了明确判断，但其中的财务评价、用户数据、市场预测和竞争动机推测，需要分别看待。
Wes Roth’s fantasy-sports project connects AI research, artwork, coding, deployment, and model competition. Its most revealing moments involve mistaken identities and unreliable connections, showing why delegating imple...
Wes Roth通过自建的幻想体育项目Blood Bench，展示多模型如何协作完成研究、美术、编码与部署。模型联赛中出现的身份混淆和连接故障，也揭示了这套流程的评测边界：实现工作可以委托，系统是否按预期运行、比赛结果能说明什么，仍需要人来判断。
Hippocratic AI co-founder and CEO Munjal Shah argues that vertical AI businesses can differentiate through narrowly defined responsibilities, specialized engineering, safety governance, and service delivery. His stronge...
Hippocratic AI联合创始人兼CEO Munjal Shah以医疗电话智能体为例，讨论垂直公司的价值如何建立在明确的任务边界、领域工程、安全治理和服务交付之上。他认为，低成本AI的重要机会在于提供过去因成本过高而无法开展的服务。不过，访谈中的经营数据、安全表现与筛查成效均来自他的自述，需要与独立验证的结果区分。
Nodalo builder Dan Jeffries joins Sam Charrington to examine what personal and collaborative agents actually require: less maintenance, useful context transfer, disciplined tools, editable outputs, and explicit privacy...
在这场约54分钟的访谈中，Nodalo 构建者 Dan Jeffries 与 Sam Charrington 从智能体的维护负担谈到多人协作、长期记忆、确定性工具和隐私架构，继而讨论本地部署、推理成本与软件护城河。贯穿对话的问题是：用户最终完成了什么，又为此承担了多少管理、维护和判断。
In this hour-long conversation, the Cost Plus Drugs co-founder connects transparent drug prices, modular manufacturing and direct provider contracts to a larger question: who captures the benefits of cheaper technology?...
在这场约一小时的访谈中，Cost Plus Drugs联合创始人马克·库班以药品销售、模块化制造和直接医疗合同，阐述自己的医疗改革思路。他把公开价格、数据权利和风险分配放在AI效率之前；个性化制药与单人创业的财富预测，则仍有待审批、知识产权、临床效果和实际交付的检验。